Stock Events

Stock Events

Kyverna Therapeutics (KYTX) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.13

-0.97

-0.82

-0.66

Details

Expected EPS

-0.751667

Actual EPS

-0.66

Surprise EPS

0.09

Surprise Percent

+12.2%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -0.66 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.